Viewing Study NCT01924195

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:22 PM
Ignite Modification Date: 2026-01-04 @ 10:17 PM
Study NCT ID: NCT01924195
Status: COMPLETED
Last Update Posted: 2015-10-28
First Post: 2013-08-12
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lung View
None Anlotinib View
None AL3818 View
None NSCLC View
None Cancer View